Home > Insider Trading > Filing (0000899243-21-047342)

Filing Details

Accession Number:: 0000899243-21-047342
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-12-08 16:53:26
Reporting Period:: 2021-12-08

Accepted Time:: 2021-12-08 16:53:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1793294	Ppd Inc.	PPD	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1405076	R Allen Thorpe	415 Mission Street, Suite 5700 San Francisco CA 94105	Yes	No	No	No
1458179	Hellman & Friedman Capital Partners Vii, L.p.	415 Mission Street, Suite 5700 San Francisco CA 94105	No	No	Yes	No
1458212	H&F Executives Vii, L.p.	415 Mission Street, Suite 5700 San Francisco CA 94105	No	No	Yes	No
1458221	Hfcp Vii (Parallel-A), L.p.	415 Mission Street, Suite 5700 San Francisco CA 94105	No	No	Yes	No
1458222	Hellman & Friedman Capital Partners Vii (Parallel), L.p.	415 Mission Street, Suite 5700 San Francisco CA 94105	No	No	Yes	No
1660963	H&F Corporate Investors Vii, Ltd.	415 Mission Street, Suite 5700 San Francisco CA 94105	No	No	Yes	No
1779162	Hellman & Friedman Investors Vii, L.p.	415 Mission Street, Suite 5700 San Francisco CA 94105	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-12-08	52,884,036	$47.50	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2021-12-08	20,244,387	$47.50	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2021-12-08	3,630,740	$47.50	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2021-12-08	359,372	$47.50	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2021-12-08	35,622,429	$47.50	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2021-12-08	15,987,409	$47.50	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2021-12-08	3,021,286	$47.50	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2021-12-08	934,469	$47.50	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2021-12-08	157,138	$47.50	No	4	S	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes

Footnotes

On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash.
Reflects securities directly held by Hellman & Friedman Capital Partners VII, L.P. ("HFCP VII").
Reflects securities directly held by Hellman & Friedman Capital Partners VII (Parallel), L.P. ("HFCP VII Parallel").
Reflects securities directly held by HFCP VII (Parallel-A), L.P. ("HFCP VII Parallel-A").
Reflects securities directly held by H&F Executives VII, L.P. ("H&F VII Executives", and together with HFCP VII, HFCP VII Parallel and HFCP VII Parallel-A, the "H&F VII Funds").
Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII").
Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel").
Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A").
Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives").
Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds").
Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.